Evidence map›Paper›PMID 36309146›Full record

SynthesisJournal of clinical epidemiology2022

Predicting COVID-19 prognosis in the ICU remained challenging: external validation in a multinational regional cohort.

Daniek A M Meijs, Sander M J van Kuijk, Laure Wynants, Björn Stessel, Jannet Mehagnoul-Schipper, Anisa Hana, Clarissa I E Scheeren, Dennis C J J Bergmans, Johannes Bickenbach, Margot Vander Laenen and 6 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Journal of clinical epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daniek A M MeijsDepartment of Intensive Care Medicine, Maastricht University Medical Centre (Maastricht UMC+), Maastricht, The Netherlands; Department of Intensive Care Medicine, Laurentius Ziekenhuis, Roermond, The Netherlands; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands. Electronic address: daniek.meijs@mumc.nl.
Sander M J van KuijkDepartment of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Laure WynantsDepartment of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Department of Development and Regeneration, KULeuven, Leuven, Belgium; Epi-centre, KULeuven, Leuven, Belgium.
Björn StesselDepartment of Intensive Care Medicine, Jessa Hospital, Hasselt, Belgium; Faculty of Medicine and Life Sciences, UHasselt, Diepenbeek, Belgium.
Jannet Mehagnoul-SchipperDepartment of Intensive Care Medicine, VieCuri Medisch Centrum, Venlo, The Netherlands.
Anisa HanaDepartment of Intensive Care Medicine, Laurentius Ziekenhuis, Roermond, The Netherlands; Department of Intensive Care Medicine, University Hospital of Zurich, Zurich, Switzerland.
Clarissa I E ScheerenDepartment of Intensive Care Medicine, Zuyderland Medisch Centrum, Heerlen/Sittard, The Netherlands.
Dennis C J J BergmansDepartment of Intensive Care Medicine, Maastricht University Medical Centre (Maastricht UMC+), Maastricht, The Netherlands; School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, The Netherlands.
Johannes BickenbachDepartment of Intensive Care Medicine, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
Margot Vander LaenenDepartment of Intensive Care Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.
Luc J M SmitsDepartment of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
Iwan C C van der HorstDepartment of Intensive Care Medicine, Maastricht University Medical Centre (Maastricht UMC+), Maastricht, The Netherlands; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.
Gernot MarxDepartment of Intensive Care Medicine, University Hospital Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany.
Dieter MesottenFaculty of Medicine and Life Sciences, UHasselt, Diepenbeek, Belgium; Department of Intensive Care Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.
Bas C T van BusselDepartment of Intensive Care Medicine, Maastricht University Medical Centre (Maastricht UMC+), Maastricht, The Netherlands; Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands; Department of Epidemiology, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
CoDaP Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesMany prediction models for coronavirus disease 2019 (COVID-19) have been developed. External validation is mandatory before implementation in the intensive care unit (ICU). We selected and validated prognostic models in the Euregio Intensive Care COVID (EICC) cohort. STUDY DESIGN AND

settingIn this multinational cohort study, routine data from COVID-19 patients admitted to ICUs within the Euregio Meuse-Rhine were collected from March to August 2020. COVID-19 models were selected based on model type, predictors, outcomes, and reporting. Furthermore, general ICU scores were assessed. Discrimination was assessed by area under the receiver operating characteristic curves (AUCs) and calibration by calibration-in-the-large and calibration plots. A random-effects meta-analysis was used to pool results.

results551 patients were admitted. Mean age was 65.4 ± 11.2 years, 29% were female, and ICU mortality was 36%. Nine out of 238 published models were externally validated. Pooled AUCs were between 0.53 and 0.70 and calibration-in-the-large between -9% and 6%. Calibration plots showed generally poor but, for the 4C Mortality score and Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) score, moderate calibration.

conclusionOf the nine prognostic models that were externally validated in the EICC cohort, only two showed reasonable discrimination and moderate calibration. For future pandemics, better models based on routine data are needed to support admission decision-making.

Indexed as

COVID-19AgedCohort StudiesCritical CareFemaleHospital MortalityHumansIntensive Care UnitsMaleMiddle AgedPrognosisRetrospective StudiesCOVID-19Critical careIntensive care unitPredictionPrognosisSARS-CoV-2

Identifiers

PMID36309146
PMCPMC9605784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.